Transfusionsmedizin
Scope & Guideline
Uniting expertise to improve blood transfusion safety and efficacy.
Introduction
Aims and Scopes
- Transfusion Safety and Efficacy:
The journal emphasizes studies that assess the safety and efficacy of blood products and transfusion practices, including pathogen reduction technologies and transfusion strategies in various clinical settings. - Innovations in Cellular Therapies:
A significant focus is placed on advancements in cellular therapies, including CAR-T cell therapies and stem cell transplantation, exploring their applications and implications for patient care. - Immunohematology and Antibody Detection:
Research related to immunohematology, including the detection of blood group antibodies and alloimmunization, is a core area, addressing the complexities of blood compatibility. - Clinical Guidelines and Best Practices:
The journal serves as a platform for developing and disseminating clinical guidelines and best practices in transfusion medicine, ensuring that practitioners are informed of the latest evidence-based approaches. - Emerging Infectious Diseases and Blood Safety:
It addresses the impact of emerging infectious diseases on blood safety, including the use of convalescent plasma for treating COVID-19 and other viral infections. - Patient-Centered Research:
There is a growing emphasis on research that considers patient outcomes, quality of life, and personalized medicine approaches in transfusion practices.
Trending and Emerging
- CAR-T Cell Therapy and Immunotherapy:
There is an increasing number of studies focused on CAR-T cell therapy, reflecting a growing interest in immunotherapy as a transformative approach for treating various hematological conditions. - Impact of COVID-19 on Transfusion Practices:
Research examining the effects of the COVID-19 pandemic on transfusion practices, including the use of convalescent plasma and adaptations in donor safety protocols, has surged in relevance. - Genetic and Genomic Approaches in Transfusion Medicine:
Emerging themes include the application of genetic and genomic technologies for better understanding blood group genetics, alloimmunization, and tailored therapies. - Patient-Centric Approaches and Quality of Life:
There is a noticeable trend towards incorporating patient perspectives in transfusion medicine research, focusing on quality of life and patient-reported outcomes. - Pathogen Reduction Technologies:
Innovations in pathogen reduction technologies are increasingly prominent, addressing safety concerns and enhancing the quality of blood products.
Declining or Waning
- Traditional Blood Component Processing Methods:
With the rise of new technologies and methods, traditional blood processing techniques are receiving less attention as researchers explore more innovative approaches to improve safety and efficacy. - General Blood Donation Practices:
There appears to be a waning interest in studies focused solely on general blood donation practices, as more specific and advanced topics related to transfusion medicine take precedence. - Historical Perspectives on Transfusion Medicine:
Research articles that provide historical insights into transfusion medicine are becoming less frequent, as the emphasis shifts towards contemporary and future-oriented research. - Non-specific Transfusion Reactions:
The frequency of studies focusing on non-specific transfusion reactions has decreased, possibly due to improved safety measures and better understanding of transfusion-related complications. - Regulatory Frameworks for Blood Products:
While still relevant, there is less emphasis on discussing regulatory frameworks for blood products compared to the past, as the focus shifts towards practical applications and clinical outcomes.
Similar Journals
Clinical Laboratory
Innovating Insights in Laboratory MedicineClinical Laboratory is a reputable journal dedicated to the interdisciplinary field of clinical biochemistry, genetics, and molecular biology. Published by CLIN LAB PUBL in Germany, this journal provides a platform for the dissemination of original research, reviews, and key insights into laboratory practices and innovations that play a crucial role in modern medicine and diagnostics. With an ISSN of 1433-6510 and a consistent publication history since its inception in 1964 and converging through 2024, it is indexed within the Scopus database, ranking in the 30th percentile among its peers. Although classified in the third quartile for 2023 in the field, Clinical Laboratory continues to contribute valuable knowledge and fosters collaboration among researchers, professionals, and students. Notably, it does not currently operate as an Open Access journal, which emphasizes its commitment to maintaining high-quality peer-reviewed content accessible through institutional and library subscriptions. For those in the domain, Clinical Laboratory serves as a vital resource for the latest advancements and trends shaping the future of clinical laboratory science.
BRITISH JOURNAL OF HAEMATOLOGY
Elevating Hematology Knowledge for Better Patient CareBritish Journal of Haematology, published by Wiley, is a leading journal in the field of hematology, with an impressive impact factor reflecting its significance in the medical research community. Established in 1955, the journal has consistently contributed to advancing knowledge in hematology, currently holding a prestigious Q1 ranking in the Scopus category of Hematology, placing it in the top 18% of the field. The journal encompasses a broad range of topics including clinical and laboratory aspects of blood disorders and hematological malignancies, making it an essential resource for hematologists, researchers, and healthcare professionals. With its commitment to publishing top-tier research and clinical studies, the British Journal of Haematology plays a critical role in shaping treatment approaches and improving patient outcomes worldwide. Please note that this journal does not offer Open Access options, ensuring that published content is rigorously curated for quality and relevance.
GEMATOLOGIYA I TRANSFUZIOLOGIYA
Transforming Insights into Lifesaving PracticesGEMATOLOGIYA I TRANSFUZIOLOGIYA is an esteemed journal published by the MINISTERSTVO ZDRAVOOKHRANENIYA in the Russian Federation, focusing on the vital fields of hematology and transfusion medicine. With a rich history dating back to its inception in 1983, the journal plays a significant role in disseminating critical research and advancements in these areas, particularly relevant given the evolving landscape of medical science. As a recognized publication, it is indexed in Scopus and holds a Q4 category ranking in Hematology for 2023, reflecting its niche but important contributions to the field. Researchers, healthcare professionals, and students can look forward to a variety of peer-reviewed articles that not only address contemporary issues but also pave the way for innovative practices in hematology. Although it does not currently offer open access, the journal remains a valuable resource for those seeking to stay informed about the latest findings and developments.
TRANSFUSION MEDICINE REVIEWS
Exploring the intersection of laboratory science and transfusion medicine.TRANSFUSION MEDICINE REVIEWS is a prestigious journal dedicated to the advanced study of transfusion medicine and its related fields, published by W B SAUNDERS CO-ELSEVIER INC. With an outstanding reputation, it boasts an impressive impact factor and consistently ranks in the top quartile (Q1) across multiple categories, including Biochemistry (Medical), Clinical Biochemistry, and Hematology. Researchers will find valuable insights through its extensive coverage of pertinent topics, with a focus on the integration of clinical practices and laboratory science. While the journal does not currently offer open access, its content remains accessible through various institutional subscriptions, ensuring that vital information is available to the global scientific community. With a continuous publication history from 1987 to 2024, TRANSFUSION MEDICINE REVIEWS serves as a vital resource for academics, healthcare professionals, and students who seek to stay abreast of the latest research findings and clinical practices in transfusion medicine.
Hematology
Advancing Hematology: Where Innovation Meets InsightHematology is a distinguished open-access journal published by Taylor & Francis Ltd, dedicated to advancing research and knowledge in the field of hematology. Established in 1996, the journal has continually evolved to meet the needs of a growing community of researchers and practitioners, providing a vital platform for disseminating innovative findings and clinical insights. With its impact factor reflecting a robust commitment to quality scholarship, Hematology has achieved a respectable position in its category as evidenced by its Q3 ranking in the Hematology category and ranks #85 out of 137 in the Scopus index, which positions it in the 38th percentile among its peers. The journal’s open-access policy, initiated in 2019, further enhances its reach and accessibility, allowing a broad audience of professionals, researchers, and students to engage with high-quality research without barriers. By covering a wide range of topics related to blood disorders, treatment methodologies, and emerging therapies, Hematology stands as an essential resource for those dedicated to innovation in this critical area of healthcare.
CURRENT OPINION IN HEMATOLOGY
Advancing hematological knowledge for better patient care.CURRENT OPINION IN HEMATOLOGY is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the latest advancements and insights in the field of hematology. With an impressive impact factor and ranked in the first quartile (Q1) of its category, this journal serves as a vital resource for researchers, clinicians, and students seeking to stay informed on contemporary issues and emerging trends in hematological research and treatment. Established in 1994, it showcases critical reviews, expert commentary, and systematic analyses across a broad spectrum of hematology topics, contributing significantly to clinical and experimental knowledge through its robust editorial standards. While offering traditional subscription access, CURRENT OPINION IN HEMATOLOGY remains committed to providing a platform that bridges the gap between fundamental research and clinical application, making it indispensable for professionals dedicated to advancing patient care and scientific understanding in hematology.
Asian Journal of Transfusion Science
Connecting global minds in transfusion medicine.Asian Journal of Transfusion Science, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, is a prominent open-access journal dedicated to the interdisciplinary fields of hematology and immunology. With an ISSN of 0973-6247 and E-ISSN 1998-3565, it serves as a crucial platform for researchers, clinicians, and students from around the globe, facilitating the dissemination of high-quality, peer-reviewed research. Established in 2007, the journal has consistently aimed to advance scientific knowledge in transfusion practices, enhancing patient care and safety in transfusion medicine. Despite its recent categorization in the Q4 quartile within both Hematology and Immunology, the journal is making strides toward greater visibility in the academic community, with plans for expanded reach and increased citation impact. With its commitment to open-access publishing, the Asian Journal of Transfusion Science ensures that invaluable research findings are readily accessible to all stakeholders, thereby bolstering collaborative efforts in transfusion science and related disciplines.
Turkish Journal of Hematology
Connecting researchers and clinicians to elevate hematology practices.Turkish Journal of Hematology is an esteemed publication dedicated to advancing the field of hematology, producing influential research since its inception in 1999 under the auspices of GALENOS PUBL HOUSE. With an Open Access model, it facilitates widespread dissemination of knowledge, allowing researchers, clinicians, and students to stay abreast of the latest developments in blood disorders and treatments. With an ISSN of 1300-7777 and an E-ISSN of 1308-5263, the journal holds a commendable position in the academic community, evidenced by its 2023 Q3 ranking within the hematology category and its standing at #80 out of 137 in the Scopus database, placing it in the 41st percentile. Covering a wide scope of topics within hematology, this journal serves as a critical resource for disseminating innovative research and clinical practices pertinent to the ongoing challenges faced in this vital area of medicine. With its continuous publication until 2024, Turkish Journal of Hematology remains a beacon for enhancing the understanding and treatment of hematological conditions within the Turkish and global medical communities.
Egyptian Journal of Haematology
Pioneering Knowledge in Hematologic Malignancies and CareThe Egyptian Journal of Haematology, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, stands as a pivotal resource in the field of hematology, particularly within the context of Egypt and the broader Middle Eastern region. This journal is dedicated to disseminating high-quality research that explores the latest advancements in blood disorders, hematologic malignancies, and transfusion medicine. With a focus on original research, case studies, and reviews, it aims to provide a comprehensive platform for hematologists, researchers, and healthcare professionals to enhance their understanding and management of hematological conditions. Although it is not an open-access journal, the rigorous peer-review process ensures that only the most impactful studies are published, contributing to the journal's reputation in the academic community. The Egyptian Journal of Haematology serves as an essential tool for advancing knowledge, improving clinical outcomes, and fostering collaboration among experts in the field.
BLOOD
Advancing the Science of Hematology.BLOOD, published by the American Society of Hematology, is a premier peer-reviewed journal in the fields of Biochemistry, Cell Biology, Hematology, and Immunology. With an impressive impact factor and ranking in the top quartiles (Q1) across multiple disciplines, BLOOD is essential reading for researchers and professionals seeking to stay updated on the latest advancements in hematology and related fields. The journal has been a cornerstone of hematological research since its inception in 1946, providing a platform for rigorous scientific inquiry and discourse. Its commitment to publishing high-quality original research, comprehensive reviews, and insightful editorials makes it a vital resource for students, practitioners, and scientists alike. By offering exceptional access to influential publications, BLOOD continues to shape the future of hematology and enhance understanding of blood-related disorders, marking its vital role in advancing both basic and clinical research.